Treatment(s) already received-Lumpectomy - Page 2 of 5 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Lumpectomy Posts on Medivizor

Searching for triple negative breast cancer patients to test the effectiveness of pembrolizumab

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate how effective pembrolizumab (Keytruda) is at treating triple negative breast cancer. The main outcome to be investigated is the invasive disease free survival. Other outcomes include the overall survival (time from treatment until death from any cause) and side effects. This trial is taking place...

Read More

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study compared the side effects and outcome of two drug regimens in women with high-risk node-positive breast cancer (BC). Both treatment regimens were found to have similar survival outcomes. Some background Standard treatment in node positive BC (cancer that has spread to the lymph nodes) consists of two categories of...

Read More

Can we predict recurrence of ductal carcinoma in situ after breast conserving surgery?

Posted by on Jul 25, 2016 in Breast cancer | 1 comment

In a nutshell Patients with ductal carcinoma in situ (DCIS) who undergo breast conserving surgery (BCS) are at risk of cancer recurrence. This study aimed to identify risk factors which could predict the likelihood of recurrence. It was found that a low tumor grade, presence of cancerous cells in the area directly around the tumor, the presence of a...

Read More

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More

Breast cancer; what are the risks of cancer returning following surgery?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the overall risks of breast cancer recurrence (return of the cancer) following two types of breast cancer surgery. Some background Breast cancer treatments may include surgery; a mastectomy is the removal of the entire breast while breast-conserving surgery is the removal of the breast cancer but not the...

Read More

Cancer sub-types; what are the characteristics?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to distinguish whether the characteristics of breast cancer could depend on the focality of the tumor. Some background Breast cancer can be characterized as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found (focality); unifocal...

Read More

Radiation to the lymph nodes in stage II and II breast cancer; is it necessary?

Posted by on Jun 11, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the effectiveness of radiotherapy treatment (uses high-energy radiation to kill cancer cells by damaging their DNA) on women with breast cancer who have previously had surgery. Some background Breast- conserving surgery (removes the breast cancer but not the breast itself) is just one method of breast...

Read More

Breast cancer in premenopausal women; hormone treatment with ovarian suppression

Posted by on Jun 5, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine the effectiveness of exemestane (Aromasin) to treat premenopausal women with breast cancer and treatment outlook in comparison to tamoxifen (Nolvadex). Some background Tamoxifen is a type of hormone therapy used to treat breast cancer. This type of treatment is generally specific for hormone receptor...

Read More